Local Anesthetics Practice Questions

Q: What is the main barrier to the diffusion of local anesthetics across nerve fibers?

Perineurium. The **perineurium** is the primary diffusion barrier for local anesthetics (LA) due to its unique anatomical and physiological properties. ### Why Perineurium is Correct The perineurium is the connective tissue sheath that surrounds a bundle of nerve fibers (fascicle). It is composed of layers of flattened mesothelial cells joined by **tight junctions** (zonulae occludentes). These tight junctions create a high-resistance metabolically active barrier that regulates the internal environment of the fascicle. In clinical anesthesia, this layer acts as the most significant mechanical and chemical hurdle that a local anesthetic molecule must penetrate to reach the nerve axons. ### Why Other Options are Incorrect * **Epineurium (A):** This is the outermost layer of the nerve. While it is thick and composed of loose connective tissue and fat, it is relatively permeable and does not possess tight junctions. It provides structural support but is not the main barrier to diffusion. * **Endoneurium (B):** This is the delicate connective tissue surrounding individual axons. By the time the LA reaches the endoneurium, it has already bypassed the major barriers; thus, it does not serve as a primary diffusion obstacle. ### High-Yield Clinical Pearls for NEET-PG * **Order of Blockade:** Small myelinated fibers (Aδ) and unmyelinated fibers (C) are blocked before large myelinated fibers (Aα). * **Mantle vs. Core:** Fibers located in the **mantle** (outer part of the fascicle) are blocked first, while **core** fibers (inner part) are blocked last. * **pH and Diffusion:** Local anesthetics are weak bases. Only the **non-ionized (lipid-soluble)** form can diffuse across the perineurium. In acidic environments (e.g., infected tissue), the ionized form predominates, leading to poor diffusion and block failure.

Q: What is the success rate for intraligamentary anaesthesia?

Injection under strong back pressure. **Explanation:** Intraligamentary anesthesia (also known as Periodontal Ligament or PDL injection) is a technique where the local anesthetic is delivered directly into the periodontal ligament space. **Why "Injection under strong back pressure" is correct:** The periodontal ligament space is extremely narrow and dense. To successfully force the anesthetic solution through the small pores of the cribriform plate (lamina dura) and into the cancellous bone surrounding the tooth apex, significant resistance must be encountered. This resistance is felt by the clinician as **strong back pressure** on the syringe plunger. If there is no back pressure, it indicates that the needle is not properly seated or the solution is leaking into the oral cavity, leading to anesthetic failure. **Analysis of Incorrect Options:** * **Option A (Strong forward pressure):** This is a distractor term. While the clinician applies forward force, the diagnostic hallmark of a successful PDL injection is the "back pressure" exerted by the confined anatomical space against the fluid. * **Option C (Supragingival tissue):** Injecting here would result in simple mucosal anesthesia and would not reach the deep periodontal fibers or the periapical nerves. * **Option D (Buccal labial fold):** This describes the site for a standard infiltration (supraperiosteal injection), not an intraligamentary technique. **High-Yield Clinical Pearls for NEET-PG:** * **Primary Indication:** Used when conventional blocks fail or when single-tooth anesthesia is required without lingering soft tissue numbness. * **Equipment:** Often performed using specialized high-pressure syringes (e.g., Citoject or Ligmaject). * **Onset:** Rapid (30 seconds), similar to an intravascular injection. * **Contraindication:** Should be avoided in primary teeth to prevent **enamel hypoplasia** of the underlying permanent tooth bud.

Q: What is the most significant adverse consequence of accidental intravenous administration of a local anesthetic?

Seizures. **Explanation:** The most significant and immediate adverse consequence of accidental intravenous (IV) administration of local anesthetics (LA) is **Systemic Toxicity (LAST)**, which primarily affects the Central Nervous System (CNS) and the Cardiovascular System. **Why Seizures are the Correct Answer:** Local anesthetics work by blocking voltage-gated sodium channels. When injected IV, they rapidly cross the blood-brain barrier. At lower toxic concentrations, they selectively inhibit **inhibitory cortical pathways** (GABAergic neurons). This leads to unopposed excitatory activity, resulting in premonitory symptoms (perioral numbness, metallic taste, tinnitus) followed rapidly by **generalized tonic-clonic seizures**. At even higher doses, global CNS depression and cardiovascular collapse occur. **Why Other Options are Incorrect:** * **Bronchoconstriction:** This is not a typical feature of LA toxicity. In fact, lidocaine is often used to *blunt* the airway response during intubation. * **Hepatic damage:** While amide LAs are metabolized in the liver, acute IV toxicity causes immediate neurological/cardiac crises rather than hepatotoxicity. * **Nerve damage:** This is usually a result of direct mechanical trauma, high pressure, or chemical neurotoxicity from *local* perineural injection, not systemic IV administration. **High-Yield Clinical Pearls for NEET-PG:** 1. **Bupivacaine** is the most cardiotoxic LA; it binds "fast in, slow out" to cardiac sodium channels. 2. **Treatment of Choice:** **Intravenous Lipid Emulsion (20% Intralipid)** acts as a "lipid sink" to sequester the drug. 3. **Potentiating Factors:** Acidosis, hypercapnia, and hypoxia increase the risk and severity of CNS toxicity. 4. **Order of Toxicity:** CNS symptoms (seizures) usually precede Cardiovascular symptoms (arrhythmias/arrest), except with Bupivacaine where they may occur simultaneously.

Q: Among the local anesthetics, which one is associated with vasoconstriction and is commonly used with adrenaline?

1:200000. **Explanation** Local anesthetics (LAs) are often combined with **Adrenaline (Epinephrine)** to induce localized vasoconstriction. This serves three primary purposes: it decreases systemic absorption (reducing toxicity), prolongs the duration of action, and provides a bloodless surgical field. **Why 1:200,000 is the Correct Answer:** The standard, most widely used concentration of adrenaline added to local anesthetics (like Lidocaine or Bupivacaine) for infiltration and nerve blocks is **1:200,000**. This corresponds to **5 micrograms/mL**. This concentration provides an optimal balance between effective local vasoconstriction and minimal systemic cardiovascular side effects (such as tachycardia or hypertension). **Analysis of Incorrect Options:** * **1:20:** This is an extremely concentrated, lethal dose and is never used clinically. * **1:20,000:** This concentration is too high for routine regional anesthesia. It is occasionally used in dentistry for localized hemostasis but carries a higher risk of tissue necrosis and systemic pressor effects. * **1:100,000:** While used in some dental cartridges (10 mcg/mL), it is not the standard "textbook" concentration for general surgical local anesthesia, where 1:200,000 is preferred to maximize the safety margin. **High-Yield Clinical Pearls for NEET-PG:** * **Maximum Doses:** Adding adrenaline increases the maximum safe dose of Lidocaine from **3 mg/kg to 7 mg/kg** and Bupivacaine from **2 mg/kg to 3 mg/kg**. * **Contraindications:** Adrenaline-containing LAs must **never** be used in areas supplied by end-arteries (e.g., fingers, toes, nose, ears, and penis) due to the risk of ischemia and gangrene. * **Cocaine Exception:** Cocaine is the only local anesthetic that possesses intrinsic vasoconstrictive properties by inhibiting norepinephrine reuptake.

Q: What is the maximum recommended dose of lignocaine with adrenaline in mg/kg?

7. **Explanation:** The maximum recommended dose of Lignocaine (Lidocaine) is determined by its systemic toxicity profile. The addition of **adrenaline (epinephrine)**, typically in a 1:200,000 concentration, causes local vasoconstriction. This slows the systemic absorption of the anesthetic, prolonging its duration of action and allowing for a higher safe dosage threshold. * **Correct Answer (C - 7 mg/kg):** For Lignocaine **with** adrenaline, the maximum safe dose is **7 mg/kg**. This is a high-yield value frequently tested in NEET-PG. * **Option B (5 mg/kg):** This is the maximum recommended dose for Lignocaine **plain** (without adrenaline). Exceeding this increases the risk of Local Anesthetic Systemic Toxicity (LAST). * **Option A (4 mg/kg):** This is below the standard safe limit for Lignocaine but is closer to the maximum dose for Bupivacaine (2-3 mg/kg). * **Option D (10 mg/kg):** This exceeds the safety margin for Lignocaine and would likely result in CNS or cardiovascular toxicity. **High-Yield Clinical Pearls for NEET-PG:** 1. **Absolute Max Dose:** Regardless of weight, the total dose of Lignocaine with adrenaline should generally not exceed **500 mg**. 2. **Bupivacaine Limits:** Plain = 2 mg/kg; with adrenaline = 3 mg/kg. 3. **Toxicity Sequence:** CNS symptoms (perioral numbness, metallic taste, seizures) usually precede Cardiovascular Collapse (CVC) with Lignocaine. 4. **Antidote:** Intravenous **Lipid Emulsion (20% Intralipid)** is the specific treatment for LAST.

Q: What is the cause of the sensation of tissue tearing during the administration of local anesthesia?

Barb on the needle. ### Explanation **Correct Answer: D. Barb on the needle** The sensation of "tissue tearing" or "dragging" during the insertion or withdrawal of a needle is a classic clinical sign of a **barbed needle**. A barb is a microscopic hook at the tip of the needle, usually caused by the needle tip striking bone during a previous injection attempt or accidental contact with a hard surface. As the needle moves through the tissues, this hook catches and tears the connective tissue fibers, causing both the characteristic sensation for the clinician and significant post-operative pain or trismus for the patient. **Analysis of Incorrect Options:** * **A. Passage through a cyst:** This typically results in a "loss of resistance" or a sudden "pop" followed by ease of flow, rather than a tearing sensation. * **B. Passage through a muscle:** Muscle penetration usually offers steady, firm resistance. While it may cause discomfort, it does not produce a tactile tearing sensation unless the needle is damaged. * **C. Passage through an area of infection:** Infected tissues are often more vascular and edematous (acidic environment). Injection here is usually associated with intense burning pain due to the pH shift and increased pressure, but not a mechanical tearing sensation. **High-Yield NEET-PG Pearls:** * **Prevention:** Always discard a needle after it has touched bone or if it has been used for more than 3–4 penetrations in the same patient. * **Safety Check:** To check for a barb before injection, draw the needle backward across a sterile gauze pad; if it snags the fibers, the needle is barbed and must be replaced. * **Complication:** Using a barbed needle significantly increases the risk of **needle breakage**, a rare but serious complication in regional anesthesia.

Q: What is the maximum dose of lignocaine without adrenaline that can be administered to a patient?

4 mg/kg body weight. **Explanation:** Lignocaine (Lidocaine) is an amide-linked local anesthetic that acts by blocking voltage-gated sodium channels. The maximum safe dose is determined by the risk of **Systemic Toxicity (LAST)**, which occurs when plasma levels rise due to excessive administration or accidental intravascular injection. 1. **Why Option A is Correct:** For **plain lignocaine (without adrenaline)**, the maximum recommended dose is **3–4 mg/kg body weight**. This limit is set to prevent CNS side effects (like seizures) and cardiovascular collapse. In a standard 70 kg adult, this equates to approximately 200–280 mg. 2. **Why Option C is Incorrect:** **7 mg/kg** is the maximum dose for **lignocaine with adrenaline (1:200,000)**. Adrenaline acts as a vasoconstrictor, slowing systemic absorption, prolonging the duration of action, and reducing peak plasma levels, thereby allowing a higher dose to be administered safely. 3. **Why Options B and D are Incorrect:** These values do not correspond to standard safety guidelines for lignocaine. 5 mg/kg is sometimes cited in older texts but is generally considered less conservative than 4 mg/kg in modern practice. 9 mg/kg exceeds the safety threshold for both plain and adrenaline-combined lignocaine. **High-Yield Clinical Pearls for NEET-PG:** * **Bupivacaine:** Max dose is **2 mg/kg** (plain) and **3 mg/kg** (with adrenaline). It is significantly more cardiotoxic than lignocaine. * **Treatment of Toxicity:** Intravenous **Lipid Emulsion (20% Intralipid)** is the specific antidote for Local Anesthetic Systemic Toxicity (LAST). * **Order of Blockade:** Autonomic fibers > Pain/Temperature (A-delta & C) > Touch/Pressure > Motor. * **Metabolism:** Amides (like Lignocaine) are metabolized in the **liver** (P450 system), whereas Esters (like Procaine) are metabolized by **plasma pseudocholinesterase**.

Q: What is the most important adverse effect of intravenous administration of a large dose of an amide anesthetic?

Seizures. **Explanation:** The correct answer is **Seizures**. This question tests your knowledge of **Local Anesthetic Systemic Toxicity (LAST)**. **Why Seizures?** Local anesthetics (LAs) act by blocking voltage-gated sodium channels. When an amide anesthetic (like Lidocaine or Bupivacaine) is accidentally administered intravenously in large doses, it crosses the blood-brain barrier. In the Central Nervous System (CNS), LAs initially inhibit **inhibitory cortical pathways** (GABAergic neurons). This leads to unopposed excitatory activity, manifesting as muscle twitching, tremors, and ultimately, **generalized tonic-clonic seizures**. CNS toxicity typically precedes cardiovascular toxicity (except with Bupivacaine, where they may occur simultaneously). **Analysis of Incorrect Options:** * **Bronchoconstriction:** LAs actually possess mild bronchodilatory properties and are sometimes used to blunt the pressor response during intubation. Allergic reactions (which could cause bronchospasm) are rare with amides; they are more common with "ester" group LAs due to the metabolite PABA. * **Hepatic damage:** While amide LAs are metabolized in the liver, acute large doses cause rapid systemic toxicity (CNS/CVS) rather than acute hepatic necrosis. * **Renal failure:** LAs do not have direct nephrotoxic effects. Renal failure is not a feature of acute LAST. **High-Yield Clinical Pearls for NEET-PG:** * **Sequence of CNS Toxicity:** Perioral numbness → Metallic taste → Tinnitus → Visual disturbances → **Seizures** → Coma/Respiratory arrest. * **Drug of Choice for LAST:** **Intravenous Lipid Emulsion (20% Intralipid)**. It acts as a "lipid sink" to sequester the drug. * **Potency & Toxicity:** Bupivacaine is highly cardiotoxic (blocks sodium channels during diastole). Ropivacaine and Levobupivacaine are safer alternatives with less CNS/CVS toxicity.

Question 1

What is the main barrier to the diffusion of local anesthetics across nerve fibers?

Accepted Answer

Perineurium

Answer

Epineurium

Answer

Endoneurium

Answer

All of the above

Question 2

What is the success rate for intraligamentary anaesthesia?

Accepted Answer

Injection under strong back pressure

Answer

Injection under strong forward pressure

Answer

Injection over supragingival tissue

Answer

Injection over buccal labial fold

Question 3

What is the most significant adverse consequence of accidental intravenous administration of a local anesthetic?

Accepted Answer

Seizures

Answer

Bronchoconstriction

Answer

Hepatic damage

Answer

Nerve damage

Question 4

Among the local anesthetics, which one is associated with vasoconstriction and is commonly used with adrenaline?

Accepted Answer

1:200000

Answer

1:20

Answer

1:20000

Answer

1:100000

Question 5

What is the maximum recommended dose of lignocaine with adrenaline in mg/kg?

Accepted Answer

7

Answer

4

Answer

5

Answer

10

Question 6

On the administration of local anesthetic in an area of infection, what is the predominant form of the local anesthetic?

Accepted Answer

Increased cationic form

Answer

Buffering capacity of the local anesthetic is decreased

Answer

Decreased concentration of the uncharged base

Answer

Decreased concentration of charged cations

Question 7

What is the cause of the sensation of tissue tearing during the administration of local anesthesia?

Accepted Answer

Barb on the needle

Answer

Passage through a cyst

Answer

Passage through a muscle

Answer

Passage through an area of infection

Question 8

What is the maximum dose of lignocaine without adrenaline that can be administered to a patient?

Accepted Answer

4 mg/kg body weight

Answer

5 mg/kg body weight

Answer

7 mg/kg body weight

Answer

9 mg/kg body weight

Question 9

What is the most important adverse effect of intravenous administration of a large dose of an amide anesthetic?

Accepted Answer

Seizures

Answer

Bronchoconstriction

Answer

Hepatic damage

Answer

Renal failure

Question 10

Alkalization of local anesthetic solutions by the addition of sodium bicarbonate has the following benefits, except:

Accepted Answer

Decreases systemic toxicity

Answer

Speeds the onset

Answer

Improves quality

Answer

Decreases pain at the injection site

Local Anesthetics — MCQs

Local Anesthetics — MCQs

On this page

Practice by Chapter

Want unlimited practice?